BioCentury | Jul 17, 2019
Preclinical News

July 17 Preclinical Quick Takes: Using CRISPR to edit TCRs, plus AAVs with synthetic promoters and AI for cancer diagnosis

...surface expression and responded to antigen-specific stimulation in vitro . Busch is a co-founder of Stage Cell Therapeutics GmbH...
BioCentury | May 5, 2016
Product R&D

Cell therapy's yada yada yada

...commercial production. Also in 2015, Juno leased a manufacturing facility in Washington state and acquired Stage Cell Therapeutics GmbH...
BioCentury | Jun 8, 2015
Strategy

Juno's progressive thinking

...Juno paid $58.6 million in cash and issued 486,000 shares to buy the 95% of Stage Cell Therapeutics GmbH...
BioCentury | Jun 3, 2015
Top Story

Juno acquires antibody company X-Body

...a series of deals for Juno. Last month, the company acquired cell therapy manufacturing company Stage Cell Therapeutics GmbH...
BioCentury | May 18, 2015
Company News

Stage Cell Therapeutics, Juno Therapeutics deal

...Juno acquired cell therapy manufacturing company Stage Cell Therapeutics in a cash and stock deal. Juno will operate...
...advanced automation technology and EUR30 million ($33.5 million) tied to Stage Cell’s existing clinical pipeline. Stage Cell Therapeutics GmbH...
BioCentury | May 12, 2015
Company News

Juno acquires manufacturing play Stage

...Juno Therapeutics Inc. (NASDAQ:JUNO) acquired cell therapy manufacturing company Stage Cell Therapeutics GmbH (Gottingen, Germany) to help produce its...
Items per page:
1 - 6 of 6
BioCentury | Jul 17, 2019
Preclinical News

July 17 Preclinical Quick Takes: Using CRISPR to edit TCRs, plus AAVs with synthetic promoters and AI for cancer diagnosis

...surface expression and responded to antigen-specific stimulation in vitro . Busch is a co-founder of Stage Cell Therapeutics GmbH...
BioCentury | May 5, 2016
Product R&D

Cell therapy's yada yada yada

...commercial production. Also in 2015, Juno leased a manufacturing facility in Washington state and acquired Stage Cell Therapeutics GmbH...
BioCentury | Jun 8, 2015
Strategy

Juno's progressive thinking

...Juno paid $58.6 million in cash and issued 486,000 shares to buy the 95% of Stage Cell Therapeutics GmbH...
BioCentury | Jun 3, 2015
Top Story

Juno acquires antibody company X-Body

...a series of deals for Juno. Last month, the company acquired cell therapy manufacturing company Stage Cell Therapeutics GmbH...
BioCentury | May 18, 2015
Company News

Stage Cell Therapeutics, Juno Therapeutics deal

...Juno acquired cell therapy manufacturing company Stage Cell Therapeutics in a cash and stock deal. Juno will operate...
...advanced automation technology and EUR30 million ($33.5 million) tied to Stage Cell’s existing clinical pipeline. Stage Cell Therapeutics GmbH...
BioCentury | May 12, 2015
Company News

Juno acquires manufacturing play Stage

...Juno Therapeutics Inc. (NASDAQ:JUNO) acquired cell therapy manufacturing company Stage Cell Therapeutics GmbH (Gottingen, Germany) to help produce its...
Items per page:
1 - 6 of 6